Entera Bio
Sector: Healthcare & Life Sciences
About Entera Bio
home new - EnteraBio Skip to content Home About Us Leadership Scientific Advisory Board Board of Directors Technology Pipeline Pipeline overview Osteoporosis Hypoparathyroidism SBS & Obesity Publications Investors Share Information Share Chart Email Alerts Press Releases SEC Filing Investor Calendar Corporate Governance Board of Directors Management Committee Composition Investor Resources Investo
Products
N-Tab®
Entera’s Proprietary Platform is designed to simultaneously stabilize the peptide in the gastrointestinal tract and promote its absorption into the bloodstream